Chlorphenesin Carbamate

Chlorphenesin Carbamate

SCHEMBL2939463

NC(=O)OCC(O)COc1ccc(Cl)cc1.NC(=O)OCC(O)COc1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 1.00
LMNA P02545 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPK1 P28482 2/20 0.51
POLB P06746 2/20 0.50
MAPT P10636 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KCNH2 Q12809 2/20 0.47
CACNA1G O43497 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
TSHR P16473 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
CNR1 P21554 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorphenesin Carbamate SCHEMBL34492 1.00 CYP1A2 (1.00) CYP1A2LMNASMN1; SMN2KDM4EMAPK1
SCHEMBL5354587 0.85 CYP1A2 (0.74) CYP1A2LMNAKDM4EMAPK1POLB
SCHEMBL18309828 0.84 CYP1A2 (0.72) CYP1A2LMNASMN1; SMN2KDM4EPOLB
SCHEMBL21977218 0.83 CYP1A2 (0.71) CYP1A2LMNASMN1; SMN2KDM4EPOLB
Carbamic Acid SCHEMBL34493 0.81 CYP1A2 (0.68) CYP1A2LMNAMAPK1POLBMAPT
SCHEMBL9654944 0.80 CYP1A2 (0.67) CYP1A2LMNASMN1; SMN2MAPK1POLB
SCHEMBL11140249 0.80 CYP1A2 (0.66) CYP1A2LMNAMAPK1POLBMAPT
SCHEMBL11649744 0.79 CYP1A2 (0.65) CYP1A2LMNASMN1; SMN2MAPK1POLB
SCHEMBL11546333 0.79 CYP1A2 (0.65) CYP1A2LMNAMAPK1POLBMAPT
SCHEMBL5360069 0.78 CYP1A2 (0.64) CYP1A2LMNASMN1; SMN2MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9539216-B2 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same INNERCAP TECHNOLOGIES, INC. (US) 2017-01-10 US disclosed
US-20160136100-A1 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME INNERCAP TECHNOLOGIES, INC. 2016-05-19 US disclosed
US-9241911-B2 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same INNERCAP TECHNOLOGIES, INC. 2016-01-26 US disclosed
US-20140212482-A1 MULTI-PHASE, MULTI-COMPARTMENT, CAPSULAR DELIVERY APPARATUS AND METHODS FOR USING SAME INNERCAP TECHNOLOGIES, INC. 2014-07-31 US disclosed
US-7670612-B2 Supplying active materials in various phases in single dosage multicompartment capsule INNERCAP TECHNOLOGIES, INC. (US) 2010-03-02 US disclosed